Updates are available Correction dated 2025-12-24
Click to view Correction: https://doi.org/10.1007/s12325-025-03464-5
-
Authors
Kikuno, Kyoko https://orcid.org/0009-0005-8903-3574
Asada, Ryuta https://orcid.org/0000-0003-2228-1272
Ishihara, Takuma https://orcid.org/0000-0002-1979-8310
Morishige, Ken-ichirou https://orcid.org/0000-0001-7869-1428
Chikazawa, Kenro https://orcid.org/0000-0002-8839-4483
Furui, Tatsuro https://orcid.org/0000-0003-4855-219X
Isobe, Masanori https://orcid.org/0000-0002-5899-9932
-
Funding
Funding for this research was provided by:
Mochida Pharmaceutical Company
Gifu University
- License Information
-
More Information
Article History
Received: 29 August 2025
Accepted: 3 October 2025
First Online: 24 October 2025
Change Date: 24 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12325-025-03464-5
Conflict of Interest
: Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Ken-ichirou Morishige, Kenro Chikazawa, Tatsuro Furui, and Masanori Isobe declare that they have no conflicts of interest.
: The study protocol was approved by the Clinical Research Review Committee of the Nagoya City University Hospital (approval number: 2021A001-23b001), and informed consent was obtained from all participants before study enrollment. This study adhered to the ethical principles of the Declaration of Helsinki. All data were anonymized to protect the participants’ privacy. No personally identifiable information is included in the dataset. Additionally, stringent protective measures, e.g., encrypted data storage and restricted access protocols, were implemented to ensure data confidentiality. The protocol was finalized before enrollment began.
